Why Choose HematoPAC™-HSC-CB?
- Robust starting material: High-quality CD34⁺ HSCs ready for translational and preclinical workflows
- Donor consistency: Matched immune cell sets from the same donor reduce experimental variability
- Speed-to-product: Under 24-hour processing preserves optimal viability and yield
- Comprehensive QC: Backed by detailed donor data, viability/purity metrics, and immunophenotyping profiles
- Regulatory-ready sourcing: IRB-approved protocols, ethical cord blood sourcing, and full donor documentation
Applications
HematoPAC™-HSC-CB is ideal for:
- Development of HSC-based allogeneic cell therapies and iPSC starting material
- Preclinical modeling of hematopoietic and immune reconstitution
- Engineering of CAR-T or CAR-NK cells via HSC differentiation
- High-throughput screening of blood lineage differentiation
Comparative research using matched donor immune cells across workflows
Quality & Compliance
- Sourced under ethical, IRB-approved protocols with informed consent
- Expedited processing within 24 hours to safeguard quality attributes
- Detailed Certificate of Analysis included with each lot – documenting purity, donor metadata, and QC data